image
Healthcare - Biotechnology - NASDAQ - US
$ 7.05
-7.18 %
$ 1.12 B
Market Cap
-5.88
P/E
INCOME STATEMENT
63.7 M REVENUE
9.03%
-172 M OPERATING INCOME
-108.52%
-194 M NET INCOME
-139.68%
EFFICIENCY
Earnings Waterfall Ocular Therapeutix, Inc.
image
Revenue 63.7 M
Cost Of Revenue 5.63 M
Gross Profit 58.1 M
Operating Expenses 230 M
Operating Income -172 M
Other Expenses 21.7 M
Net Income -194 M
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)64m(6m)58m(230m)(172m)(22m)(194m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 63.7 58.4 51.5 43.5 17.4 4.2 2.0 1.9 1.9 1.8 0.8 0 10 K
GROSS PROFIT
Cost Of Revenue 5.6 5.3 4.5 4.4 2.1 2.3 0.5 0.5 0.4 0.3 91 K 10.5 7 K
Gross Profit 58.1 53.2 47.0 39.1 15.3 1.9 1.5 1.5 1.4 1.4 0.7 (10.5) 3 K
OPERATING INCOME
Operating Expenses 229.9 135.5 125.6 117.2 78.2 87.7 60.6 63.4 44.8 39.6 27.8 12.9 13.7
Selling, General and Administrative Expenses 102.2 74.5 72.1 67.1 49.5 46.6 23.7 32.5 17.7 13.0 8.9 2.4 2.1
Research and Development Expenses 127.6 61.1 53.5 50.1 28.7 41.1 36.9 30.9 27.1 26.6 18.9 10.5 11.5
Operating Income (171.8) (82.4) (78.7) (78.0) (62.8) (85.8) (59.1) (61.9) (43.3) (38.2) (27.1) (12.9) (13.7)
PRE-TAX INCOME
Interest Income Expense 13.6 11.3 7.0 6.7 6.8 6.1 1.7 1.9 1.7 1.7 1.1 0.4 0.4
Total Other Income (21.7) 1.6 7.6 71.5 (92.8) (0.6) (0.9) (1.5) (1.4) (1.6) (1.6) (0.4) (0.4)
Pre-Tax Income (193.5) (80.7) (71.0) (6.6) (155.6) (86.4) (60.0) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
NET INCOME
Tax Provision 0 0 (7.6) 4.3 4.0 3.6 (2.3) 0.3 0.8 1.0 0.1 0.5 0.3
Net Income (193.5) (80.7) (63.4) (10.8) (159.6) (89.9) (57.7) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
EPS 1.22 1.09 0.83 0.14 2.63 1.99 1.51 2.2 1.8 1.71 2.69 4.51 4.77